At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IVA Inventiva S.A.
Trading 07-10 10:20:20 EDT
4.30
-0.23
-5.08%
High4.51Low4.30Vol131.58K
Open4.50D1 Closing4.53Amplitude4.64%
Mkt Cap1.01BTradable Cap786.90MTotal Shares236.00M
T/O577.06KT/O Rate0.07%Tradable Shares183.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

European Equities Traded in the US as American Depositary Receipts Rise Thursday
MT Newswires Live  ·  07-09 23:10
European Equities Traded in the US as American Depositary Receipts Rise Thursday
Press Release: Results of the Votes of the Combined Shareholders' General Meeting of June 30, 2026
Dow Jones  ·  07-03
Press Release: Results of the Votes of the Combined Shareholders' General Meeting of June 30, 2026
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)
TIPRANKS  ·  06-15
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Rhythm Pharmaceuticals (RYTM) and Belite Bio, Inc. ADR (BLTE)
Press Release: Statement of Total Voting Rights and Shares Forming The Company's Share Capital as of May 22, 2026
Dow Jones  ·  06-10
Press Release: Statement of Total Voting Rights and Shares Forming The Company's Share Capital as of May 22, 2026
Press Release: Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents
Dow Jones  ·  06-10
Press Release: Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)
TIPRANKS  ·  06-08
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (APGE), Inventiva (IVA) and Roche Holding AG (OtherRHHVF)
Inventiva (IVA) Receives a Buy from Barclays
TIPRANKS  ·  06-04
Inventiva (IVA) Receives a Buy from Barclays
Inventiva files automatic mixed securities shelf
TIPRANKS  ·  06-02
Inventiva files automatic mixed securities shelf
eGain Launches AI Agent IVA to Deliver Accurate, Conversational Customer Service
GlobeNewswire  ·  05-06
eGain Launches AI Agent IVA to Deliver Accurate, Conversational Customer Service
Inventiva Names Malkomes as CFO Ahead of Lanifibranor Phase 3 Readout
Dow Jones  ·  04-23
Inventiva Names Malkomes as CFO Ahead of Lanifibranor Phase 3 Readout
Inventiva CFO Jean Volatier to switch roles, Axel-Sven Malkomes to succeed
TIPRANKS  ·  04-23
Inventiva CFO Jean Volatier to switch roles, Axel-Sven Malkomes to succeed
AcadeMedia Buys Dutch IVA Business School to Bolster Adult Education Push
TIPRANKS  ·  04-16
AcadeMedia Buys Dutch IVA Business School to Bolster Adult Education Push
Analysts Are Bullish on These Healthcare Stocks: Inventiva (IVA), Stereotaxis (STXS)
TIPRANKS  ·  04-07
Analysts Are Bullish on These Healthcare Stocks: Inventiva (IVA), Stereotaxis (STXS)
Barclays Sticks to Its Buy Rating for Inventiva (IVA)
TIPRANKS  ·  04-02
Barclays Sticks to Its Buy Rating for Inventiva (IVA)
Guggenheim Keeps Their Buy Rating on Inventiva (IVA)
TIPRANKS  ·  04-01
Guggenheim Keeps Their Buy Rating on Inventiva (IVA)
Stock Track | Inventiva S.A. Soars 6.02% Intraday on Analyst Bullishness
Stock Track  ·  03-31
Stock Track | Inventiva S.A. Soars 6.02% Intraday on Analyst Bullishness
Wall Street Analysts Are Bullish on Top Healthcare Picks
TIPRANKS  ·  03-31
Wall Street Analysts Are Bullish on Top Healthcare Picks
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)
TIPRANKS  ·  03-31
Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)
Stock Track | Inventiva Plunges 14.6% in Pre-market After Reporting Steep Revenue Decline
Stock Track  ·  03-31
Stock Track | Inventiva Plunges 14.6% in Pre-market After Reporting Steep Revenue Decline
Inventiva 2025 Loss Narrows, Revenue Falls
MT Newswires Live  ·  03-31
Inventiva 2025 Loss Narrows, Revenue Falls

Introduction

Company Name.
Inventiva S.A.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.
Issue price:
--